ASTS
Price
$58.00
Change
-$0.98 (-1.66%)
Updated
Aug 3, 10:34 AM (EDT)
Capitalization
17.62B
14 days until earnings call
Intraday BUY SELL Signals
SYNX
Price
$1.01
Change
-$0.01 (-0.98%)
Updated
Jul 31 closing price
Capitalization
6.7M
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTS vs SYNX

ASTS vs SYNX Comparison Chart in %
View a ticker or compare two or three
VS
ASTS vs. SYNX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTS is a Hold and SYNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (ASTS: $58.98 vs. SYNX: $1.01)
Brand notoriety: ASTS and SYNX are both not notable
Both companies represent the Telecommunications Equipment industry
Current volume relative to the 65-day Moving Average: ASTS: 30% vs. SYNX: 17%
Market capitalization -- ASTS: $17.62B vs. SYNX: $6.7M
ASTS [@Telecommunications Equipment] is valued at $17.62B. SYNX’s [@Telecommunications Equipment] market capitalization is $6.7M. The market cap for tickers in the [@Telecommunications Equipment] industry ranges from $457.17B to $0. The average market capitalization across the [@Telecommunications Equipment] industry is $20.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTS’s FA Score shows that 1 FA rating(s) are green whileSYNX’s FA Score has 1 green FA rating(s).

  • ASTS’s FA Score: 1 green, 4 red.
  • SYNX’s FA Score: 1 green, 4 red.
According to our system of comparison, ASTS is a better buy in the long-term than SYNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTS’s TA Score shows that 6 TA indicator(s) are bullish while SYNX’s TA Score has 3 bullish TA indicator(s).

  • ASTS’s TA Score: 6 bullish, 4 bearish.
  • SYNX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ASTS is a better buy in the short-term than SYNX.

Price Growth

ASTS (@Telecommunications Equipment) experienced а +4.95% price change this week, while SYNX (@Telecommunications Equipment) price change was -4.72% for the same time period.

The average weekly price growth across all stocks in the @Telecommunications Equipment industry was -2.35%. For the same industry, the average monthly price growth was -10.17%, and the average quarterly price growth was +18.41%.

Reported Earning Dates

ASTS is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Telecommunications Equipment (-2.35% weekly)

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASTS($17.6B) has a higher market cap than SYNX($6.7M). SYNX YTD gains are higher at: -5.607 vs. ASTS (-18.794).
ASTSSYNXASTS / SYNX
Capitalization17.6B6.7M262,647%
EBITDA-528.68MN/A-
Gain YTD-18.794-5.607335%
P/E RatioN/AN/A-
Revenue84.9MN/A-
Total Cash3.03BN/A-
Total Debt2.99BN/A-
FUNDAMENTALS RATINGS
ASTS: Fundamental Ratings
ASTS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASTSSYNX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ASTS
Daily Signal:
Gain/Loss:
SYNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAI307.50-0.29
-0.09%
Kadant
PHG26.30-0.14
-0.53%
Koninklijke Philips NV
DRUG73.26-1.37
-1.84%
Bright Minds Biosciences
PLBY1.11-0.04
-3.48%
Playboy Inc
XTLB2.68-0.15
-5.30%
XTL Biopharmaceuticals Ltd